Inogen (INGN) Shareholder's Equity Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.60% |
| Dec 31, 2025 | 10.57% |
| Sep 30, 2025 | 6.35% |
| Jun 30, 2025 | 6.34% |
| Mar 31, 2025 | 3.15% |
| Dec 31, 2024 | -15.11% |
| Sep 30, 2024 | -19.61% |
| Jun 30, 2024 | -31.73% |
| Mar 31, 2024 | -31.78% |
| Dec 31, 2023 | -31.13% |
| Sep 30, 2023 | -34.26% |
| Jun 30, 2023 | -22.93% |
| Mar 31, 2023 | -21.49% |
| Dec 31, 2022 | -19.67% |
| Sep 30, 2022 | -10.25% |
| Jun 30, 2022 | -3.88% |
| Mar 31, 2022 | 0.56% |
| Dec 31, 2021 | 5.89% |
| Sep 30, 2021 | 10.90% |
| Jun 30, 2021 | 5.64% |
| Mar 31, 2021 | 2.59% |
| Dec 31, 2020 | 1.45% |
| Sep 30, 2020 | 2.73% |
| Jun 30, 2020 | 5.19% |
| Mar 31, 2020 | 7.89% |
| Dec 31, 2019 | 11.02% |
| Sep 30, 2019 | 17.81% |
| Jun 30, 2019 | 25.06% |
| Mar 31, 2019 | 30.67% |
| Dec 31, 2018 | 36.73% |
| Sep 30, 2018 | 31.62% |
| Jun 30, 2018 | 28.46% |
| Mar 31, 2018 | 27.78% |
| Dec 31, 2017 | 24.69% |
| Sep 30, 2017 | 28.20% |
| Jun 30, 2017 | 28.07% |
| Mar 31, 2017 | 28.03% |
| Dec 31, 2016 | 35.87% |
| Sep 30, 2016 | 32.85% |
| Jun 30, 2016 | 26.83% |
| Mar 31, 2016 | 22.85% |
| Dec 31, 2015 | 13.43% |
| Sep 30, 2015 | 14.06% |
| Jun 30, 2015 | 15.43% |
| Mar 31, 2015 | 13.59% |
| Dec 31, 2014 | 289.43% |
| Mar 31, 2014 | 232.01% |
| Dec 31, 2013 | 22.78% |